Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Pazopanib hydrochloride

EU orphan designation number: EU/3/06/382
Active ingredient: Pazopanib hydrochloride
Indication: Treatment of renal cell carcinoma
Sponsor: Glaxo Group Limited
Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/07/2006 Orphan designation EMEA/OD/013/06 (2006)3092 of 29/06/2006
05/12/2008 Transfer of orphan designation EMEA/OD/013/06/T/01 (2008)8089 of 03/12/2008
13/04/2010 Removal of orphan designation from Community Register